Evolving Adjuvant Treatments for HER2+ Early Breast Cancer - Episode 6

Ongoing Research Efforts in HER2+ Early Breast Cancer

,

Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD, discuss ongoing research efforts in HER2-positive early breast cancer.

EP. 1: Prognosis and Survival Outcomes for HER2+ Early Breast Cancer
EP. 2: Evolving and Current Standards of Care for HER2+ Early Breast Cancer
EP. 3: AE Management With Neratinib in HER2+ Early Breast Cancer
EP. 4: Unmet Needs in HER2+ Early Breast Cancer
EP. 5: Clinical Benefits With Neratinib in HER2+ Early Breast Cancer
Now Viewing
EP. 6: Ongoing Research Efforts in HER2+ Early Breast Cancer